Sign inSubscribe

target directory

anticoagulant solutions no anticoagulant solutions anticoagulant management clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.

Validated reports

1

Directory type

target

Association rule

normalized field

NCT04241380
Source recordAI-normalized

Anticoagulation Medicine in Surgical Repair for Total Anomalous Pulmonary Venous Connection: a Randomize Multi-centers Study

Total anomalous pulmonary venous connection (TAPVC) is a complex congenital heart disease, requiring surgical repair. Pulmonary venous obstruction (PVO) is the major complication, with limited effective reinterventions and poor outcomes. This trial aims at investigating that postoperative anticoagulant management reduce the incidence of PVO.

AI analysis

Indication: Total Anomalous Pulmonary Venous Connection

Modality: small molecule

Target: Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Sponsor: Guangdong Provincial People's Hospital

Source URL: ClinicalTrials.gov

Source updated: Feb 19, 2020

Ingested: Jun 11, 2026

Model: trialsignal-ai-v1

Validation: validated

Matched by target_normalized: Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

View original source fields

Condition raw: Total Anomalous Pulmonary Venous Connection

Condition normalized: Total Anomalous Pulmonary Venous Connection

Modality raw: small molecule

Modality normalized: small molecule

Target raw: Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Target normalized: Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Open report